James A. Frank, Ph.D.
- Associate Professor of Chemical Physiology and Biochemistry, School of Medicine
- Joint Appointment, Vollum Institute
- Graduate Program in Biomedical Sciences, School of Medicine
- Neuroscience Graduate Program, School of Medicine
Biography
James Frank completed his Bachelor's degree in Chemistry at the University of British Columbia in Vancouver, where he worked in the lab of Prof. Stephen G. Withers. There, he developed fluorescent glycosides for the detection of glycosidases in high-throughput screens. Frank then traveled overseas for an industry job at Corden Pharma LLC near Basel, Switzerland, where he developed a large-scale synthesis of a complex glycolipid pharmaceutical. He obtained his Ph.D. in Organic Chemistry at the Ludwig Maximilian University of Munich in Germany in the lab of Prof. Dirk Trauner, where his research focused on the synthesis/evaluation of photo-switchable lipids. In 2017, Frank joined the bioelectronics group of Prof. Polina Anikeeva at Massachusetts Institute of Technology, where he engineered fiber-based implants to apply these photochemical probes to control behavior in freely moving rodents. He joined the Vollum Institute in 2018 as a Vollum Fellow and Research Assistant Professor, where his research interests focus on the roles of lipids on cell physiology. In 2021, Frank was named Assistant Professor in OHSU's Department of Chemical Physiology & Biochemistry, with a joint appointment in the Vollum.
The Frank lab will develop tools to illuminate the molecular mechanisms underlying membrane-localized signaling events, as well as interrogate their roles in neurological disorders and addictive behavior.
Education and training
-
Degrees
- B.Sc., 2012, University of British Columbia
- Ph.D., 2017, Ludwig Maximilian University of Munich
Areas of interest
- chemical biology
- lipid
- endocannabinoid
- neural circuits
- optical control
Additional information
Publications
Selected publications
- * Corresponding author # Co-first author Frank lab trainees (OHSU)
- Garza, S.J.#; Tobias, J.A.#; Ni, J.; Frank, J.A.* Photorelease of Anandamide at the Cell Plasma Membrane with Optically-Cleavable Targeted Ligands. ChemRxiv. DOI: 10.26434/chemrxiv.15005963/v1
- Viray, A.E.G.; Frank, J.A.* (2025) The photoswitchable cannabinoid azo-HU308 enables optical control of Ca2+ dynamics in INS-1 b-cells via off-target effects on TRPC channels. FEBS Open Bio. DOI: 10.1002/2211-5463.70146
- Garza, S.#; Kicin, B.#; Sarott, R.C.; Pfaff, P.; Kosar, M.; Weishaar, T.; Schnacke, P.; Lobingier, B.; Carreira, E.M.*; Frank, J.A.* (2025) Real-Time Optical Control of CB1 Receptor Signaling In Vitro with Tethered Photoswitchable (-)-trans-D9-Tetrahydrocannabinol Derivatives. Journal of the American Chemical Society, 147 (27), 23482-23491. DOI: 10.1021/jacs.4c18379
- Howe, C.A.; Icka-Araki, D.; Viray, A.E.G.; Garza, S.; Frank, J.A.* (2024) Optical control of TRPV1 channels in vitro with tethered photopharmacology. ACS Chemical Biology, 19 (7), 1466-1473. DOI: 10.1021/acschembio.4c00052
- Kosar, M.; Sarott R.C.; Sykes, D.A.; Viray, A.E.G.; Vitale, RM.; Tomašević, N.; Li. X.; Ganzoni, R.L.Z.; Kicin, B.; Reichert, L.; Patej, K.J.; Gómez-Bouzó, U.; Guba, W.; McCormick, P.J.; Hua, T.; Gruber, C.W.; Veprintsev, D.B.; Frank, J.A.*: Grether, U.*; Carreira, E.M.* (2024) Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists. ACS Central Science, 10 (5), 956-968. DOI: 10.1021/acscentsci.3c01461
- Kosar, M.; Sykes, D.A.; Viray, A.E.G.; Vitale, R.M.; Sarott, R.C.; Ganzoni, R.L.; Onion, D.; Tobias, J.A.; Leippe, P.; Ullmer, C.; Zirwes, E.A.; Guba, W.; Grether, U.*; Frank, J.A.*; Veprintsev, D.*; Carreira, E.M.* (2023) Platform Reagents Enable Synthesis of Ligand-Directed Covalent Probes: Study of Cannabinoid Receptor 2 in Live Cells. Journal of the American Chemical Society, 145 (28), 15094-15108. DOI: 10.11.463883
- Tobias, J.A.; Rajic, G.; Viray, A.E.G.; Icka-Araki, D.; Frank, J.A.* (2021) Genetically-targeted endocannabinoid uncaging enables optical control of GPR55 in pancreatic β-cells. Chemical Science, 12, 13506-13512. DOI: 10.1039/D1SC02527A
- Sarott, R.C.; Viray, A.E.G.; Pfaff, P.; Sadybekov, A.; Rajic, G.; Katrich, V.; Carreira, E.M.*; Frank, J.A.* (2021) Optical Control of Cannabinoid Receptor 2-Mediated Ca2+ Release Enabled By Synthesis of Photoswitchable Probes. Journal of the American Chemical Society, 143 (2), 746-743. DOI: 10.1021/jacs.0c08926
- Frank, J.A.#*; Antonini, M-J.#; Chiang, P-H.; Canales, A.; Konrad, D.; Garwood, I.; Rajic, G.; Koehler, F.; Fink, Y.; Anikeeva, P.* (2020) In vivo photopharmacology enabled by multifunctional fibers. ACS Chemical Neuroscience, 11 (22), 3802-3813. DOI: 10.1021/acschemneuro.0c00577
- Westphal, M.V.#; Schafroth, M.A.#; Sarott, R.C.; Imhof, M.A.; Bold, C.P.; Leippe, P.; Mackie, K.; Trauner, D.*; Carreira, E.M.*; Frank, J.A.* (2017) Synthesis of Photoswitchable D9-Tetrahydrocannabinol Derivatives Enables Optical Control of Cannabinoid Receptor 1 Signaling. Journal of the American Chemical Society, 139, 18206−18212. DOI: 10.1021/jacs.7b06456